CCMW
CLVS

Cypress Capital Management (Wyoming)’s Clovis Oncology, Inc. CLVS Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,000
Closed -$20K – 220
2020
Q2 		$20K Buy
+3,000
New +$22.7K 0.02% 133

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s CLVS Position: Q3 2022 in Review

Cypress Capital Management (Wyoming) sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 200 shares.

Cypress Capital Management (Wyoming) first reported a position in CLVS in Q4 2014 and held it in 31 quarters. The position peaked at $1.81M in Q3 2015. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • Cypress Capital Management (Wyoming) reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 200 Clovis Oncology, Inc. shares in Q3 2022.
  • Cypress Capital Management (Wyoming) first reported a position in Clovis Oncology, Inc. in Q4 2014 and held it in 31 quarters.
  • Cypress Capital Management (Wyoming)'s Clovis Oncology, Inc. position peaked at $1.81M in Q3 2015.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q3 2022, filed 14 Nov 2022.